Drugs / PAL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02188810 | Apr 2014 → Dec 2017 | influenza | Folia Biotech Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PAL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02188810 ↗ |
| Modality | Other / unclassified | “new vaccine adjuvant (immune booster) called PAL” NCT02188810 ↗ |
| Route | Intramuscular | “Single dose administered intramuscularly.” NCT02188810 ↗ |